PWPS
AGIO icon

Pinnacle Wealth Planning Services’s Agios Pharmaceuticals AGIO Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Hold
40
– – ﹤0.01% 2526
2026
Q1 		$1.35K Hold
40
– – ﹤0.01% 2512
2025
Q4 		$1.09K Buy
+40
New +$1.4K ﹤0.01% 2576
2021
Q1 		– Sell
-2,700
Closed -$117K – 381
2020
Q4 		$117K Buy
+2,700
New +$107K 0.03% 413

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Pinnacle Wealth Planning Services's AGIO Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 40 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2526.

Pinnacle Wealth Planning Services first reported a position in AGIO in Q4 2020 and has held it in 4 quarters since. The position peaked at $117K in Q4 2020. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Pinnacle Wealth Planning Services held 40 shares of Agios Pharmaceuticals worth $1.48K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2526 holding.
  • Pinnacle Wealth Planning Services first reported a position in Agios Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Agios Pharmaceuticals position peaked at $117K in Q4 2020.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.